Introduction: Atopic dermatitis (AD) is the most common chronic inflammatory skin disorder, manifesting as recurrent, itchy eczema that often fluctuates with seasons. Since skin barrier impairment is an initiating event in AD, emollients form the foundational therapy in its management. Clinical evidence supports the us...
B. Chandra Shekar, A. Saraswat, K. Godse et al.· Cureus· 0 citations
Stem cell‐based therapies are rapidly reshaping dermatology, driven by advances in regenerative medicine, tissue engineering, and molecular therapeutics. The skin, with its intrinsic regenerative capacity and well‐defined stem cell niches, represents a uniquely accessible model for translational application....
N. Akhoon, Aseem Sharma, R. Kaul· Dermatological Reviews· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.